The Use of Autologous Mesenchymal Stem Cells for Cell Therapy of Patients with Amyotrophic Lateral Sclerosis in Belarus
作者： Yu. N. Rushkevich , S. M. Kosmacheva , G. V. Zabrodets , S. I. Ignatenko , N. V. Goncharova
DOI: 10.1007/S10517-015-3017-3
关键词:
摘要: We studied a new method of treatment amyotrophic lateral sclerosis with autologous mesenchymal stem cells. Autologous cells were injected intravenously (intact cells) or via lumbar puncture (cells committed to neuronal differentiation). Evaluation the results cell therapy after 12-month follow-up revealed slowing down disease progression in 10 patients comparison control group consisting 15 patients. The was safe for
springer.com
sci-hub.se 参考文章(16)
Ratti Ram Sharma, Kathryn Pollock, Allison Hubel, David McKenna, Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion. ,vol. 54, pp. 1418- 1437 ,(2014) , 10.1111/TRF.12421
Elise Dantuma, Stephanie Merchant, Kiminobu Sugaya, Stem cells for the treatment of neurodegenerative diseases Stem Cell Research & Therapy. ,vol. 1, pp. 37- 37 ,(2010) , 10.1186/SCRT37
S. M. Kosmacheva, N. N. Danilkovich, A. V. Shchepen’, S. I. Ignatenko, M. P. Potapnev, Effect of Platelet Releasate on Osteogenic Differentiation of Human Mesenchymal Bone Marrow Stem Cells Bulletin of Experimental Biology and Medicine. ,vol. 156, pp. 560- 565 ,(2014) , 10.1007/S10517-014-2396-1
M. Dominici, K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F.C Marini, D.S. Krause, R.J. Deans, A. Keating, D.J. Prockop, E.M. Horwitz, Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement Cytotherapy. ,vol. 8, pp. 315- 317 ,(2006) , 10.1080/14653240600855905
A. V. Shakhbazau, N. V. Petyovka, S. M. Kosmacheva, M. P. Potapnev, Neurogenic induction of human mesenchymal stem cells in fibrin 3D matrix Bulletin of Experimental Biology and Medicine. ,vol. 150, pp. 547- 550 ,(2011) , 10.1007/S10517-011-1186-2
Colin M. MacLeod, Evaluation of chemotherapeutic agents Columbia University Press. ,(1949)
Irina Badayan, Merit E. Cudkowicz, Is it too soon for mesenchymal stem cell trials in people with ALS Amyotrophic Lateral Sclerosis. ,vol. 9, pp. 321- 322 ,(2008) , 10.1080/17482960802425559
Jesse M. Cedarbaum, Nancy Stambler, Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials Journal of the Neurological Sciences. ,vol. 152, ,(1997) , 10.1016/S0022-510X(97)00237-2
Xiaoxiao Long, Marie Olszewski, Wei Huang, Morris Kletzel, Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells. Stem Cells and Development. ,vol. 14, pp. 65- 69 ,(2005) , 10.1089/SCD.2005.14.65
S. H. Appel, J. I. Engelhardt, J. S. Henkel, L. Siklos, D. R. Beers, A. A. Yen, E. P. Simpson, Y. Luo, G. Carrum, H. E. Heslop, M. K. Brenner, U. Popat, Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis Neurology. ,vol. 71, pp. 1326- 1334 ,(2008) , 10.1212/01.WNL.0000327668.43541.22